Potassium Hydroxide → 4-(2-((5-nitro-1H-indazol-3-yl)oxy)ethyl)morpholine
Reaction equation
[O:1]1[CH2:6][CH2:5][N:4]([CH2:7][CH2:8][O:9][C:10]2[C:18]3[C:13](=[CH:14][CH:15]=[C:16]([N+:19]([O-:21])=[O:20])[CH:17]=3)[N:12](C(OCC)=O)[N:11]=2)[CH2:3][CH2:2]1.[OH-].[K+]>CCO.O>[N+:19]([C:16]1[CH:17]=[C:18]2[C:13](=[CH:14][CH:15]=1)[NH:12][N:11]=[C:10]2[O:9][CH2:8][CH2:7][N:4]1[CH2:3][CH2:2][O:1][CH2:6][CH2:5]1)([O-:21])=[O:20]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of the morpholinoethoxy indazole described above (combined with a previous batch made in an identical manner) (309 mg, 0.848 mmol) in EtOH (2.0 mL) was added a solution of KOH (48 mg, 0.848 mmol) in water (1.0 mL) and the reaction mixture maintained at RT for 16 hr. The reaction mixture was then purified directly, without work-up, by SCX capture and release to afford 4-(2-((5-nitro-1H-indazol-3-yl)oxy)ethyl)morpholine as a bright yellow solid (221 mg, 86%); Rt 0.94 min (Method 2, acidic); m/z 293 (M+H)+ (ES+).
Workup
- customThe reaction mixture was then purified directly, without work-up, by SCX capture and release
Sources & evidence
- ORD record
- ord-852cd00dd74c41d890b61f4546126d45
- Source dataset
- uspto-grants-2016_02
- Patent number
- US09249125B2
Reaction notes
Loading…